Regional initiatives and evidence-generation efforts to eliminate P. vivax malaria in Latin America 05 Dec 2022
Start of ARCTIC, a feasibility study of a new Plasmodium vivax malaria treatment protocol in Thailand 22 Jul 2022
Highlights from the Partnership for Vivax Elimination (PAVE) Greater Mekong Subregion (GMS) Country Coordinator Experience Exchange 30 Apr 2022
Event Highlights from the 2022 International Conference on Plasmodium vivax Research (ICPvR) 11 Apr 2022
Single-dose Kozenis (tafenoquine) approved for children with Plasmodium vivax malaria by Australian Therapeutic Goods Administration 14 Mar 2022
P. vivax radical cure in Latin America: regional coordination to advance malaria elimination 17 Dec 2021
First real-world use of new protocol for P. vivax case management in Brazil – a Health Ministry and MMV collaboration 08 Oct 2021
New Partnership launched to accelerate elimination of relapsing P. vivax malaria that poses a risk to an estimated 2.5 billion people worldwide 14 Jul 2021
STANDARD G6PD Test receives regulatory approval by the Australian Therapeutic Goods Administration 25 May 2021
